Welcome to the official website of the Ethypharm Group. This website is regulated by the Code of Best Practices of the International Federation of Pharmaceutical Manufacturers. Some information on this site may not be in conformity with French regulations on advertising. By continuing your navigation, you accept this website's use of cookies.

Critical care

We develop, manufacture and commercialise a comprehensive range of critical care products for patients all around the world.

These medicines are used for the specialised care of patients whose condition are life-threatening and require comprehensive care and monitoring.

38 million people in Europe are admitted each year in emergency care units at hospitals


The 5 primary critical care admission diagnoses for adults*

* Source – Society of Critical Care Medicine
Respiratory system diagnosis
Acute Myocardial infarction
Intracranial haemorrhage or cerebral infarction
Percutaneous cardiovascular procedure with drug-eluting stent
Septicaemia or severe sepsis without mechanical ventilation

Our broad range of products play a key role in emergency situations

We have a broad range of injectable drugs meant for life-threatening emergencies that require immediate and fast intervention, such as a heart attack, convulsions and hypotension or/and as well in case of poisoning.

These medicines are typically administered at hospital by anaesthesiologists, surgeons or specialists in internal medicine, in theatre, intensive care or high dependency units.
First responders also administer these medicines on the field, in emergency trucks for example.

Our Critical Care products are part of the WHO recommendation list of essential medicines. We serve governmental and no governmental organisations such as MEG (Medical Export Group), IDA Foundation and MSF (Médecins sans Frontières) all around the world.
Our large range of products assist *NGO’s in everyday disaster situations

*NGO – Non Governmental Organisation



We manufacture and commercialise an in-house comprehensive range of glass ampoules addressing the principle issues in essential and emergency medicines; cardiac function and blood pressure, pain and metabolic homeostasis as well as differentiated products for specific uses such as apnoea of prematurity, emergency ENT (ear, nose and throat) surgery and paracetamol overdose.

We operate principally in the UK and the Middle East where we have a successful track-record and our critical care ampoules are widely used at hospitals in all units.

As of today, we have more than 50 different presentations of glass ampoules and hold more than 120 Marketing Authorizations



We also develop manufacture and commercialise Pre-Filled Syringes (PFS) used principally for the emergency treatment of cardiac arrest.

PFS offer significant benefits over the traditional « vial and syringe » format, by increasing dosing accuracy, safety and convenience. The usage of PFS in Critical Care is increasing at hospitals and in ambulances for many reasons such as

  • Avoiding mistakes during administration
  • Providing fast medication
  • Risk reduction related to preparation drug
  • Economic interest comparing waste of syringe prepared
  • Nursing time saving

Our Range of Pre-Filled Syringes comprises 9 products and has been designed to enhance ease of use and help improve patient safety in case of cardiopulmonary resuscitation or in the operating theatre environment.

The one-piece, critical care glass syringe that is pre-filled
and ready to use in a twist:

Ready to use out of the box
No assembly required
Clear graduation Measurements on syringe
Robust packaging minimises damage
Ready to use in a twist
This range of fully assembled, ready-to-use, pre-filled syringes (PFS), are uniquely presented in colour differentiated packaging to meet the Royal College of Anaesthetists (RCoA) recommendations where products are manufactured.
By clicking on this link, you agree to leave our website.
Are you sure?
NO     YES